October is typically volatile for stocks. But will you be needing a seat belt or a crash helmet?
What to know about October’s market-crash potential — and what you can ignore.
What to know about October’s market-crash potential — and what you can ignore.
The Fed ‘s pivot has amplified speculative risk-taking, says this analyst
A fearless stock market is facing two rising risks, says Wedbush Read Post »
Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is
Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating Read Post »
Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.
Months after cancer drug trial, Merus agrees to be bought at 41% premium Read Post »
“My husband jokes that he will never be able to retire because we do not own a home.”
Gavekal Research predicts more stock repurchases are coming, representing an additional tailwind for the current bull market.
The Trump effect on share buybacks? There’s more of them. Read Post »
Butler didn’t seem to have any concerns buying the home, known as the “steel house”, that was once ransacked by